| Defining “mutation” and “polymorphism” in the era of personal genomics R Karki, D Pandya, RC Elston, C Ferlini BMC medical genomics 8, 1-7, 2015 | 352 | 2015 |
| An investigation of common crosslinking agents on the stability of electrospun collagen scaffolds GP Huang, S Shanmugasundaram, P Masih, D Pandya, S Amara, ... Journal of Biomedical Materials Research Part A 103 (2), 762-771, 2015 | 131 | 2015 |
| Class III β-tubulin in normal and cancer tissues M Mariani, R Karki, M Spennato, D Pandya, S He, M Andreoli, P Fiedler, ... Gene 563 (2), 109-114, 2015 | 87 | 2015 |
| Epstein-Barr virus microRNA expression increases aggressiveness of solid malignancies D Pandya, M Mariani, S He, M Andreoli, M Spennato, C Dowell-Martino, ... PLoS One 10 (9), e0136058, 2015 | 31 | 2015 |
| Nek6 and Hif-1α cooperate with the cytoskeletal gateway of drug resistance to drive outcome in serous ovarian cancer M De Donato, M Fanelli, M Mariani, G Raspaglio, D Pandya, S He, ... American journal of cancer research 5 (6), 1862, 2015 | 31 | 2015 |
| Herpes virus microRNA expression and significance in serous ovarian cancer D Pandya, M Mariani, M McHugh, M Andreoli, S Sieber, S He, ... PloS one 9 (12), e114750, 2014 | 27 | 2014 |
| Detection of endometrial precancer by a targeted gynecologic cancer liquid biopsy JA Martignetti, D Pandya, N Nagarsheth, Y Chen, O Camacho, S Tomita, ... Molecular Case Studies 4 (6), a003269, 2018 | 16 | 2018 |
| Integrated multidimensional analysis is required for accurate prognostic biomarkers in colorectal cancer M Mariani, S He, M McHugh, M Andreoli, D Pandya, S Sieber, Z Wu, ... PLoS One 9 (7), e101065, 2014 | 16 | 2014 |
| ATM-Mutated pancreatic cancer: clinical and molecular response to Gemcitabine/Nab-Paclitaxel after genome-based therapy resistance C Martino, D Pandya, R Lee, G Levy, T Lo, S Lobo, RC Frank Pancreas 49 (1), 143-147, 2020 | 14 | 2020 |
| Glycemic control as an early prognostic marker in advanced pancreatic cancer I Alpertunga, R Sadiq, D Pandya, T Lo, M Dulgher, S Evans, B Bennett, ... Frontiers in Oncology 11, 571855, 2021 | 8 | 2021 |
| Treatment-emergent neuroendocrine prostate cancer with a germline BRCA2 mutation: identification of a candidate reversion mutation associated with platinum/PARP-inhibitor … D Pandya, M Shah, F Kaplan, C Martino, G Levy, M Kazanjian, S Batter, ... Molecular Case Studies 7 (1), a005801, 2021 | 8 | 2021 |
| A Community Based Pancreatic Cancer Screening Study in High-Risk Individuals: Preliminary Efficacy and Safety Results J Kandiah, T Lo, D Jin, L Melchior, TL Krebs, N Anand, S Ingram, ... Clinical and Translational Gastroenterology, 10.14309, 2022 | 4 | 2022 |
| Rapid development and use of patient-specific ctDNA biomarkers to avoid a “rash decision” in an ovarian cancer patient D Pandya, SC Camacho, MM Padron, O Camacho-Vanegas, JN Billaud, ... Molecular Case Studies 5 (6), a004648, 2019 | 3 | 2019 |
| Elevated temperature electrospinning of aqueous gelatin solution and crosslinking for tissue engineering applications DS Pandya, T Arinzeh, G Collins Bioengineering Conference, Proceedings of the 2010 IEEE 36th Annual …, 2010 | 3 | 2010 |
| Mutational analysis of circulating tumor cells in breast cancer patients by targeted clonal sequencing. X Xu, Y Shen, W Dewitt, D Pandya, FZ Bischoff, KD Crew, DL Hershman, ... Journal of Clinical Oncology 30 (15_suppl), 10516-10516, 2012 | 2 | 2012 |
| Mutations in cancer-relevant genes are ubiquitous in histologically normal endometrial tissue D Pandya, S Tomita, MP Rhenals, S Swierczek, K Reid, ... Gynecologic Oncology 185, 194-201, 2024 | | 2024 |
| Deep molecular tracking over the 12-yr development of endometrial cancer from hyperplasia in a single patient K Reid, O Camacho-Vanegas, D Pandya, SC Camacho, RF Qiao, T Kalir, ... Molecular Case Studies 9 (4), a006311, 2023 | | 2023 |
| Transformed Waldenström Macroglobulinemia Responsive to Tafasitamab Plus Lenalidomide: A Case Report SA Nasir, D Pandya, S Wojkiewicz, B Khandpur, E Downes, P Pathare, ... Cureus 14 (12), 2022 | | 2022 |
| Correction: Transformed Waldenström Macroglobulinemia Responsive to Tafasitamab Plus Lenalidomide: A Case Report SA Nasir, D Pandya, S Wojkiewicz, B Khandpur, E Downes, P Pathare, ... Cureus 14 (12), 2022 | | 2022 |
| Integrated genomic and functional characterization of type I and II endometrial cancers reveals unexpected differences in novel candidate treatments DS Pandya, S Swierczek, JN Billaud, S Farisello, M Swierczek, S Sieber, ... Cancer Research 82 (12_Supplement), 1629-1629, 2022 | | 2022 |
Cristiano FerliniAbbvieVerified email at abbvie.com
